FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1585890476> ?p ?o ?g. }

• W1585890476 endingPage "50" @default.
• W1585890476 startingPage "45" @default.
• W1585890476 abstract "Background: The administration of peroxisome proliferator‐activated receptor γ (PPARγ) agonists to low‐density lipoprotein (LDL)‐receptor‐deficient mice resulted in a reduction in the atherosclerotic lesion area in male mice, but not in female mice. The male mice also exhibited reduction in insulin resistance while the female mice did not. To further examine the relationship between PPARγ agonists, insulin resistance and atherosclerosis, we used the model of accelerated atherosclerosis in male apolipoprotein E (apoE)‐deficient mice rendered diabetic by low‐dose streptozotocin (STZ). Methods: Male, apoE‐deficient mice ( n = 48) were randomly divided into four groups. To induce diabetes, two groups received low‐dose STZ and two groups served as controls. After diabetes induction, rosiglitazone (a PPARγ agonist) was administered by oral gavage to one of the diabetic and one of the non‐diabetic groups. Results: Rosiglitazone reduced significantly the atherosclerotic aortic plaque area in both diabetic and non‐diabetic apoE‐deficient mice: 340 ± 54 vs. 201 ± 27 μmol 2 (p = 0.001) in diabetic mice; 243 ± 22 vs. 158 ± 27 μmol 2 (p = 0.001) in non‐diabetic mice. Also, rosiglitazone reduced the correlation coefficient between plasma glucose and the degree of atherosclerosis (p < 0.0025) without affecting plasma glucose levels. The rosiglitazone‐treated mice, both diabetic and non‐diabetic, had higher lipid levels. Conclusions: Rosiglitazone‐treated animals showed less atherosclerosis despite higher lipid levels and similar glucose levels. These data suggest a direct anti‐atherogenic effect of rosiglitazone on the arterial wall." @default.
• W1585890476 created "2016-06-24" @default.
• W1585890476 creator A5011028046 @default.
• W1585890476 creator A5015483670 @default.
• W1585890476 creator A5016045071 @default.
• W1585890476 creator A5022688129 @default.
• W1585890476 creator A5027887977 @default.
• W1585890476 creator A5040780841 @default.
• W1585890476 creator A5057187994 @default.
• W1585890476 creator A5070045481 @default.
• W1585890476 creator A5075176331 @default.
• W1585890476 creator A5081094932 @default.
• W1585890476 creator A5091224225 @default.
• W1585890476 date "2003-01-01" @default.
• W1585890476 modified "2023-10-14" @default.
• W1585890476 title "Rosiglitazone (PPARγ-agonist) attenuates atherogenesis with no effect on hyperglycaemia in a combined diabetes-atherosclerosis mouse model" @default.
• W1585890476 cites W1510733531 @default.
• W1585890476 cites W1583731895 @default.
• W1585890476 cites W1633340712 @default.
• W1585890476 cites W1639924204 @default.
• W1585890476 cites W1906619597 @default.
• W1585890476 cites W1968243232 @default.
• W1585890476 cites W1976621212 @default.
• W1585890476 cites W1987052134 @default.
• W1585890476 cites W2001632177 @default.
• W1585890476 cites W2064076004 @default.
• W1585890476 cites W2084724086 @default.
• W1585890476 cites W2086040049 @default.
• W1585890476 cites W2087647782 @default.
• W1585890476 cites W2094280140 @default.
• W1585890476 cites W2096773810 @default.
• W1585890476 cites W2102088235 @default.
• W1585890476 cites W2108405004 @default.
• W1585890476 cites W2159742257 @default.
• W1585890476 cites W2168332555 @default.
• W1585890476 cites W2330542318 @default.
• W1585890476 doi "https://doi.org/10.1046/j.1463-1326.2003.00240.x" @default.
• W1585890476 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12542724" @default.
• W1585890476 hasPublicationYear "2003" @default.
• W1585890476 type Work @default.
• W1585890476 sameAs 1585890476 @default.
• W1585890476 citedByCount "69" @default.
• W1585890476 countsByYear W15858904762012 @default.
• W1585890476 countsByYear W15858904762013 @default.
• W1585890476 countsByYear W15858904762014 @default.
• W1585890476 countsByYear W15858904762015 @default.
• W1585890476 countsByYear W15858904762016 @default.
• W1585890476 countsByYear W15858904762017 @default.
• W1585890476 countsByYear W15858904762019 @default.
• W1585890476 crossrefType "journal-article" @default.
• W1585890476 hasAuthorship W1585890476A5011028046 @default.
• W1585890476 hasAuthorship W1585890476A5015483670 @default.
• W1585890476 hasAuthorship W1585890476A5016045071 @default.
• W1585890476 hasAuthorship W1585890476A5022688129 @default.
• W1585890476 hasAuthorship W1585890476A5027887977 @default.
• W1585890476 hasAuthorship W1585890476A5040780841 @default.
• W1585890476 hasAuthorship W1585890476A5057187994 @default.
• W1585890476 hasAuthorship W1585890476A5070045481 @default.
• W1585890476 hasAuthorship W1585890476A5075176331 @default.
• W1585890476 hasAuthorship W1585890476A5081094932 @default.
• W1585890476 hasAuthorship W1585890476A5091224225 @default.
• W1585890476 hasConcept C126322002 @default.
• W1585890476 hasConcept C134018914 @default.
• W1585890476 hasConcept C170493617 @default.
• W1585890476 hasConcept C2777391703 @default.
• W1585890476 hasConcept C2778938600 @default.
• W1585890476 hasConcept C2779134260 @default.
• W1585890476 hasConcept C2779280383 @default.
• W1585890476 hasConcept C2779306644 @default.
• W1585890476 hasConcept C2780152017 @default.
• W1585890476 hasConcept C555293320 @default.
• W1585890476 hasConcept C57089818 @default.
• W1585890476 hasConcept C71924100 @default.
• W1585890476 hasConceptScore W1585890476C126322002 @default.
• W1585890476 hasConceptScore W1585890476C134018914 @default.
• W1585890476 hasConceptScore W1585890476C170493617 @default.
• W1585890476 hasConceptScore W1585890476C2777391703 @default.
• W1585890476 hasConceptScore W1585890476C2778938600 @default.
• W1585890476 hasConceptScore W1585890476C2779134260 @default.
• W1585890476 hasConceptScore W1585890476C2779280383 @default.
• W1585890476 hasConceptScore W1585890476C2779306644 @default.
• W1585890476 hasConceptScore W1585890476C2780152017 @default.
• W1585890476 hasConceptScore W1585890476C555293320 @default.
• W1585890476 hasConceptScore W1585890476C57089818 @default.
• W1585890476 hasConceptScore W1585890476C71924100 @default.
• W1585890476 hasIssue "1" @default.
• W1585890476 hasLocation W15858904761 @default.
• W1585890476 hasLocation W15858904762 @default.
• W1585890476 hasOpenAccess W1585890476 @default.
• W1585890476 hasPrimaryLocation W15858904761 @default.
• W1585890476 hasRelatedWork W1527372360 @default.
• W1585890476 hasRelatedWork W2036034963 @default.
• W1585890476 hasRelatedWork W2037868476 @default.
• W1585890476 hasRelatedWork W2162906147 @default.
• W1585890476 hasRelatedWork W2364632151 @default.
• W1585890476 hasRelatedWork W2378906331 @default.
• W1585890476 hasRelatedWork W2389042413 @default.
• W1585890476 hasRelatedWork W3028894677 @default.

• next